Aspire Private Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Aspire Private Capital's NVO Position: Q4 2024 in Review
Aspire Private Capital sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 220 shares — an estimated $26.2K sold.
Aspire Private Capital first reported a position in NVO in Q4 2019 and held it in 20 quarters. The position peaked at $31.4K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.
- Aspire Private Capital reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
- Aspire Private Capital sold 220 Novo Nordisk shares in Q4 2024, an estimated $26.2K.
- Aspire Private Capital first reported a position in Novo Nordisk in Q4 2019 and held it in 20 quarters.
- Aspire Private Capital's Novo Nordisk position peaked at $31.4K in Q2 2024.
- 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.
Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.